Clinical Trial Update: KPs Supplement for Inflammation, Oxidative Stress and Lipid Abnormalities in CKD Patients. [NA]

View source ↗

Summary

A completed clinical trial evaluating KPs Supplement for inflammation, oxidative stress, and lipid abnormalities in chronic kidney disease patients (Stages 3 an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Proteinuria

Drugs mentioned

• KPs Supplement

Snippet

Sponsor: National Chung Hsing University | Conditions: Chronic Kidney Disease Stage 3, Chronic Kidney Disease Stage 4 | NA | Status: COMPLETED